Reprints not available from authors.
Pharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy
Article first published online: 27 JUN 2011
© 2011 Wiley Periodicals, Inc.
Clinical and Translational Science
Volume 4, Issue 3, pages 204–209, June 2011
How to Cite
Haas, D. M., Gallauresi, B., Shields, K., Zeitlin, D., Clark, S. M., Hebert, M. F., Ren, Z., Nallani, S. C., Meslin, E. M., Feibus, K. B., Koren, G., Goebel, W. S., Easterling, T., Denne, S. C., Flockhart, D. A. and Renbarger, J. L. (2011), Pharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clinical and Translational Science, 4: 204–209. doi: 10.1111/j.1752-8062.2011.00280.x
Funding for the conference was provided by an Indiana University- Purdue University, Indianapolis Signature Center Grant to PREGMED, the Indiana University Center for Pharmacogenetics and Therapeutics Research in Maternal and Child Health.
Speakers would like to acknowledge the U.S. Food and Drug Administration, Office of Women’s Health and the National Institute for Child Health and Human Development, National Institutes of Health for providing travel funds for affiliated speakers.
- Issue published online: 27 JUN 2011
- Article first published online: 27 JUN 2011
To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration’s role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist’s role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy. Clin Trans Sci 2011; Volume 4: 204–209